Why the study?
The study was conducted to examine the influence of muscle relaxant selection on length of stay and perioperative results in adult patients undergoing open spine surgery.
Does rocuronium and sugammadex reduce length of hospital stay in adult patients undergoing open spine surgery?
Does rocuronium and sugammadex reduce length of hospital stay in adult patients undergoing open spine surgery?
In open spine surgery, using rocuronium and sugammadex does not reduce length of stay compared to cisatracurium and neostigmine, but may reduce postoperative chest radiographic abnormalities.
Muscle relaxant selection may influence LOS after open spine surgery; leaves open prospective confirmation for ERAS protocols.
Enhanced Recovery After Surgery (ERAS), an all-encompassing perioperative care approach, has been demonstrated to enhance surgical results, mitigate postoperative issues, and decrease the length of hospital stay (LOS) in diverse surgical specialties. In this retrospective study, our objective was to examine the influence of muscle relaxant selection on LOS and perioperative results in adult patients undergoing open spine surgery. Specifically, we compared 201 patients who received cisatracurium and neostigmine with 201 patients who received rocuronium and sugammadex, after 1:1 propensity score matching. The utilization of the rocuronium and sugammadex combination in anesthesia for open spinal surgery did not lead to a reduction in the LOS but was associated with a decreased incidence of postoperative chest radiographic abnormalities, including infiltration, consolidation, atelectasis, or pneumonia (p = 0.027). In our secondary analysis, multivariate analysis revealed multiple determinants influencing the prolonged LOS (>7 days) during open spine surgery. Bispectral index-guided anesthesia emerged as a protective factor, while variables such as excessive intraoperative blood loss and fluid administration as well as postoperative chest radiographic abnormalities independently contributed to prolonged LOS.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: